TreeWAS – Variant ID: rs1067352

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Showing all nodes without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C79.3 Secondary malignant neoplasm of brain and cerebral meninges	0.065	0.935	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.057	0.943	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.057	0.943	0.000
T39.1 4-Aminophenol derivatives	0.056	0.944	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.056	0.944	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.056	0.944	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.053	0.947	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.053	0.947	0.000
T42.4 Benzodiazepines	0.052	0.948	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.051	0.949	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.051	0.949	0.000
C79 Secondary malignant neoplasm of other sites	0.051	0.949	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.050	0.950	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.049	0.951	0.000
T36 Poisoning by systemic antibiotics	0.047	0.953	0.000
C79.2 Secondary malignant neoplasm of skin	0.047	0.953	0.000
C79.4 Secondary malignant neoplasm of other and unspecified parts of nervous system	0.045	0.955	0.000
C79.7 Secondary malignant neoplasm of adrenal gland	0.044	0.956	0.000
C79.0 Secondary malignant neoplasm of kidney and renal pelvis	0.044	0.956	0.000
T43.6 Psychostimulants with abuse potential	0.043	0.957	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.042	0.958	0.000
T36.0 Penicillins	0.042	0.958	0.000
T43.2 Other and unspecified antidepressants	0.042	0.958	0.000
T42.1 Iminostilbenes	0.042	0.958	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.041	0.958	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.041	0.958	0.000
T39.4 Antirheumatics, not elsewhere classified	0.041	0.959	0.000
T39.2 Pyrazolone derivatives	0.041	0.959	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.041	0.959	0.000
T39.0 Salicylates	0.041	0.959	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.040	0.959	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.040	0.960	0.000
T42.2 Succinimides and oxazolidinediones	0.040	0.960	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.040	0.960	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.040	0.960	0.000
O34.2 Maternal care due to uterine scar from previous surgery	0.040	0.960	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.039	0.961	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.038	0.961	0.000
T43.9 Psychotropic drug, unspecified	0.038	0.962	0.000
T42.0 Hydantoin derivatives	0.038	0.962	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.037	0.963	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.037	0.963	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.037	0.963	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.037	0.963	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.037	0.963	0.000
C79.8 Secondary malignant neoplasm of other specified sites	0.036	0.964	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.035	0.964	0.000
O34 Maternal care for known or suspected abnormality of pelvic organs	0.035	0.965	0.000
T40.4 Other synthetic narcotics	0.035	0.965	0.000
T36.4 Tetracyclines	0.034	0.966	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.034	0.966	0.000
T36.9 Systemic antibiotic, unspecified	0.034	0.966	0.000
T36.8 Other systemic antibiotics	0.034	0.966	0.000
T36.7 Antifungal antibiotics, systemically used	0.034	0.966	0.000
T36.6 Rifamycins	0.034	0.966	0.000
T36.5 Aminoglycosides	0.034	0.966	0.000
T36.2 Chloramphenicol group	0.034	0.966	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.034	0.966	0.000
C79.9 Secondary malignant neoplasm, unspecified site	0.034	0.966	0.000
T42.3 Barbiturates	0.034	0.966	0.000
O34.4 Maternal care for other abnormalities of cervix	0.033	0.966	0.000
O34.8 Maternal care for other abnormalities of pelvic organs	0.032	0.967	0.000
T46.1 Calcium-channel blockers	0.032	0.968	0.000
T48.5 Anti-common-cold drugs	0.032	0.968	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.032	0.968	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.031	0.969	0.000
C79.1 Secondary malignant neoplasm of bladder and other and unspecified urinary organs	0.031	0.969	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.031	0.969	0.000
T47.2 Stimulant laxatives	0.031	0.969	0.000
T47.4 Other laxatives	0.031	0.969	0.000
T36.3 Macrolides	0.031	0.969	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.030	0.969	0.000
T48.4 Expectorants	0.030	0.969	0.000
T48.3 Antitussives	0.030	0.969	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.030	0.969	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.030	0.969	0.000
T48.0 Oxytocic drugs	0.030	0.969	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.030	0.970	0.000
T46.7 Peripheral vasodilators	0.030	0.970	0.000
T47.6 Antidiarrhoeal drugs	0.030	0.970	0.000
T41.5 Therapeutic gases	0.029	0.971	0.000
T41.4 Anaesthetic, unspecified	0.029	0.971	0.000
T41.3 Local anaesthetics	0.029	0.971	0.000
T41.2 Other and unspecified general anaesthetics	0.029	0.971	0.000
T41.1 Intravenous anaesthetics	0.029	0.971	0.000
T41.0 Inhaled anaesthetics	0.029	0.971	0.000
C79.6 Secondary malignant neoplasm of ovary	0.029	0.971	0.000
T38.9 Other and unspecified hormone antagonists	0.029	0.971	0.000
T38.7 Androgens and anabolic congeners	0.029	0.971	0.000
T38.4 Oral contraceptives	0.029	0.971	0.000
T38.2 Antithyroid drugs	0.029	0.971	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.029	0.971	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.029	0.971	0.000
T47.7 Emetics	0.029	0.971	0.000
T47.5 Digestants	0.029	0.971	0.000
T47.3 Saline and osmotic laxatives	0.029	0.971	0.000
T38.0 Glucocorticoids and synthetic analogues	0.029	0.971	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.029	0.971	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.029	0.971	0.000
T50.1 Loop [high-ceiling] diuretics	0.029	0.971	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.029	0.971	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.028	0.971	0.000
T40.6 Other and unspecified narcotics	0.029	0.971	0.000
T38.5 Other oestrogens and progestogens	0.028	0.971	0.000
O34.7 Maternal care for abnormality of vulva and perineum	0.029	0.971	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.028	0.971	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.028	0.972	0.000
T40.8 Lysergide [LSD]	0.028	0.972	0.000
T40.7 Cannabis (derivatives)	0.028	0.972	0.000
T40.0 Opium	0.028	0.972	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.028	0.972	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.028	0.972	0.000
T37.5 Antiviral drugs	0.028	0.972	0.000
T37.4 Anthelminthics	0.028	0.972	0.000
T37.3 Other antiprotozoal drugs	0.028	0.972	0.000
T37.1 Antimycobacterial drugs	0.028	0.972	0.000
T37.0 Sulphonamides	0.028	0.972	0.000
T50.4 Drugs affecting uric acid metabolism	0.028	0.972	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.028	0.972	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.027	0.972	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.027	0.973	0.000
O34.6 Maternal care for abnormality of vagina	0.027	0.973	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.027	0.973	0.000
T49.9 Topical agent, unspecified	0.026	0.973	0.000
T49.8 Other topical agents	0.026	0.973	0.000
T49.7 Dental drugs, topically applied	0.026	0.973	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.026	0.973	0.000
T49.5 Ophthalmological drugs and preparations	0.026	0.973	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.026	0.973	0.000
T49.3 Emollients, demulcents and protectants	0.026	0.973	0.000
T49.2 Local astringents and local detergents	0.026	0.973	0.000
T49.1 Antipruritics	0.026	0.973	0.000
T50.7 Analeptics and opioid receptor antagonists	0.026	0.973	0.000
T50.5 Appetite depressants	0.026	0.973	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.026	0.973	0.000
T50.0 Mineralocorticoids and their antagonists	0.026	0.973	0.000
O34.5 Maternal care for other abnormalities of gravid uterus	0.026	0.974	0.000
O34.0 Maternal care for congenital malformation of uterus	0.026	0.974	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.026	0.974	0.000
T40.3 Methadone	0.026	0.974	0.000
O34.9 Maternal care for abnormality of pelvic organ, unspecified	0.026	0.974	0.000
T40.1 Heroin	0.025	0.975	0.000
T47.0 Histamine H(2)-receptor antagonists	0.024	0.975	0.000
T50.8 Diagnostic agents	0.024	0.975	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.024	0.976	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.024	0.976	0.000
O34.1 Maternal care for tumour of corpus uteri	0.024	0.976	0.000
T40.2 Other opioids	0.023	0.977	0.000
T40.5 Cocaine	0.023	0.977	0.000
S66.1 Injury of flexor muscle and tendon of other finger at wrist and hand level	0.000	0.977	0.023
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.023	0.977	0.000
T45.2 Vitamins, not elsewhere classified	0.023	0.977	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.023	0.977	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.023	0.977	0.000
T38.1 Thyroid hormones and substitutes	0.022	0.977	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.021	0.978	0.000
S66.2 Injury of extensor muscle and tendon of thumb at wrist and hand level	0.000	0.979	0.021
T45.4 Iron and its compounds	0.021	0.979	0.000
S66 Injury of muscle and tendon at wrist and hand level	0.000	0.979	0.021
T45.9 Primarily systemic and haematological agent, unspecified	0.021	0.979	0.000
T45.8 Other primarily systemic and haematological agents	0.021	0.979	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.021	0.979	0.000
T45.6 Fibrinolysis-affecting drugs	0.021	0.979	0.000
T45.3 Enzymes, not elsewhere classified	0.021	0.979	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.020	0.979	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.020	0.979	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.020	0.979	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.020	0.979	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.020	0.979	0.000
T44.0 Anticholinesterase agents	0.020	0.979	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.020	0.980	0.000
S66.3 Injury of extensor muscle and tendon of other finger at wrist and hand level	0.000	0.981	0.019
O34.3 Maternal care for cervical incompetence	0.018	0.981	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.018	0.982	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.017	0.983	0.000
T45.0 Antiallergic and antiemetic drugs	0.017	0.983	0.000
C83.3 Large cell (diffuse)	0.000	0.983	0.017
S66.7 Injury of multiple extensor muscles and tendons at wrist and hand level	0.000	0.983	0.017
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.983	0.017
K80.5 Calculus of bile duct without cholangitis or cholecystitis	0.016	0.984	0.000
C83.0 Small cell (diffuse)	0.000	0.984	0.015
S66.4 Injury of intrinsic muscle and tendon of thumb at wrist and hand level	0.000	0.985	0.015
T45.5 Anticoagulants	0.015	0.985	0.000
S66.9 Injury of unspecified muscle and tendon at wrist and hand level	0.000	0.985	0.015
C83.7 Burkitt's tumour	0.000	0.985	0.015
S66.5 Injury of intrinsic muscle and tendon of other finger at wrist and hand level	0.000	0.986	0.014
S66.8 Injury of other muscles and tendons at wrist and hand level	0.000	0.986	0.014
A63.0 Anogenital (venereal) warts	0.000	0.986	0.014
C83.1 Small cleaved cell (diffuse)	0.000	0.986	0.014
S66.0 Injury of long flexor muscle and tendon of thumb at wrist and hand level	0.000	0.986	0.014
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.987	0.013
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.987	0.013
C83.6 Undifferentiated (diffuse)	0.000	0.988	0.012
C83.4 Immunoblastic (diffuse)	0.000	0.988	0.012
C83.5 Lymphoblastic (diffuse)	0.000	0.988	0.012
S66.6 Injury of multiple flexor muscles and tendons at wrist and hand level	0.000	0.988	0.012
C83.2 Mixed small and large cell (diffuse)	0.000	0.988	0.012
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.988	0.012
Z57.2 Occupational exposure to dust	0.012	0.988	0.000
C81 Hodgkin's disease	0.000	0.989	0.011
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.989	0.011
Z57 Occupational exposure to risk-factors	0.011	0.989	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.989	0.011
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.989	0.011
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.989	0.010
C84.5 Other and unspecified T-cell lymphomas	0.000	0.990	0.010
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.010	0.990	0.000
C81.7 Other Hodgkin's disease	0.000	0.990	0.010
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.010	0.990	0.000
Z57.3 Occupational exposure to other air contaminants	0.010	0.990	0.000
Z57.5 Occupational exposure to toxic agents in other industries	0.009	0.990	0.000
Z63 Other problems related to primary support group, including family circumstances	0.009	0.991	0.000
C95 Leukaemia of unspecified cell type	0.000	0.991	0.009
Z63.7 Other stressful life events affecting family and household	0.009	0.991	0.000
K11.5 Sialolithiasis	0.000	0.991	0.009
C81.2 Mixed cellularity	0.000	0.991	0.009
Z56 Problems related to employment and unemployment	0.009	0.991	0.000
C84.4 Peripheral T-cell lymphoma	0.000	0.992	0.008
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.992	0.008
C81.3 Lymphocytic depletion	0.000	0.992	0.008
C86 Other specified types of T/NK-cell lymphoma	0.000	0.992	0.008
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.992	0.008
C81.0 Lymphocytic predominance	0.000	0.992	0.008
Z57.9 Occupational exposure to unspecified risk-factor	0.008	0.992	0.000
Z57.7 Occupational exposure to vibration	0.008	0.992	0.000
Z57.6 Occupational exposure to extreme temperature	0.008	0.992	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.008	0.992	0.000
Z57.1 Occupational exposure to radiation	0.008	0.992	0.000
Z57.0 Occupational exposure to noise	0.008	0.992	0.000
S42.20 Fracture of upper end of humerus (closed)	0.008	0.992	0.000
C85.0 Lymphosarcoma	0.000	0.992	0.008
Z64 Problems related to certain psychosocial circumstances	0.008	0.992	0.000
Z58 Problems related to physical environment	0.008	0.992	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.992	0.008
E27.1 Primary adrenocortical insufficiency	0.000	0.992	0.008
C95.9 Leukaemia, unspecified	0.000	0.992	0.008
C81.1 Nodular sclerosis	0.000	0.992	0.008
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.992	0.008
N18.5 Chronic kidney disease, stage 5	0.000	0.992	0.008
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.992	0.008
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.992	0.008
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.992	0.008
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.992	0.008
C84.3 Lymphoepithelioid lymphoma	0.000	0.992	0.008
C84.2 T-zone lymphoma	0.000	0.992	0.008
C84.1 Sezary's diease	0.000	0.992	0.008
E27.4 Other and unspecified adrenocortical insufficiency	0.000	0.992	0.008
Z65 Problems related to other psychosocial circumstances	0.008	0.992	0.000
Z63.4 Disappearance and death of family member	0.008	0.992	0.000
N20.0 Calculus of kidney	0.008	0.992	0.000
S02.10 Fracture of base of skull (closed)	0.008	0.992	0.000
Z56.6 Other physical and mental strain related to work	0.007	0.993	0.000
Z62 Other problems related to upbringing	0.007	0.993	0.000
Z55 Problems related to education and literacy	0.007	0.993	0.000
C79.5 Secondary malignant neoplasm of bone and bone marrow	0.007	0.993	0.000
C94 Other leukaemias of specified cell type	0.000	0.993	0.007
C91 Lymphoid leukaemia	0.000	0.993	0.007
C93 Monocytic leukaemia	0.000	0.993	0.007
Z63.6 Dependent relative needing care at home	0.007	0.993	0.000
Z61 Problems related to negative life events in childhood	0.007	0.993	0.000
Z58.5 Exposure to other pollution	0.007	0.993	0.000
Z64.0 Problems related to unwanted pregnancy	0.007	0.993	0.000
Z63.5 Disruption of family by separation and divorce	0.007	0.993	0.000
C95.0 Acute leukaemia of unspecified cell type	0.000	0.993	0.007
U80.1 Methicillin resistant agent	0.007	0.993	0.000
Z63.9 Problem related to primary support group, unspecified	0.007	0.993	0.000
Z63.3 Absence of family member	0.007	0.993	0.000
Z63.2 Inadequate family support	0.007	0.993	0.000
Z63.1 Problems in relationship with parents and in-laws	0.007	0.993	0.000
C95.7 Other leukaemia of unspecified cell type	0.000	0.993	0.007
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.993	0.007
Z56.0 Unemployment, unspecified	0.007	0.993	0.000
Z56.4 Discord with boss and workmates	0.007	0.993	0.000
Z56.7 Other and unspecified problems related to employment	0.007	0.993	0.000
C88 Malignant immunoproliferative diseases	0.000	0.993	0.007
A63 Other predominantly sexually transmitted diseases, not elsewhere classified	0.000	0.993	0.007
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.993	0.006
Z60 Problems related to social environment	0.007	0.993	0.000
Z56.5 Uncongenial work	0.006	0.993	0.000
Z56.2 Threat of job loss	0.006	0.993	0.000
Z56.1 Change of job	0.006	0.993	0.000
Z63.8 Other specified problems related to primary support group	0.006	0.993	0.000
Z56.3 Stressful work schedule	0.006	0.993	0.000
Z59 Problems related to housing and economic circumstances	0.006	0.993	0.000
Z57.8 Occupational exposure to other risk-factors	0.006	0.993	0.000
Z63.0 Problems in relationship with spouse or partner	0.006	0.993	0.000
E27 Other disorders of adrenal gland	0.000	0.994	0.006
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.994	0.006
C84.0 Mycosis fungoides	0.000	0.994	0.006
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.994	0.006
C86.4 Blastic NK-cell lymphoma	0.000	0.994	0.006
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.994	0.006
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.994	0.006
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.994	0.006
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.994	0.006
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.994	0.006
C96.8 Histiocytic sarcoma	0.000	0.994	0.006
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.994	0.006
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.994	0.006
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.994	0.006
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.994	0.006
C96.3 True histiocytic lymphoma	0.000	0.994	0.006
C96.2 Malignant mast cell tumour	0.000	0.994	0.006
C96.1 Malignant histiocytosis	0.000	0.994	0.006
C96.0 Letterer-Siwe disease	0.000	0.994	0.006
C91.9 Lymphoid leukaemia, unspecified	0.000	0.994	0.006
Z58.8 Other problems related to physical environment	0.006	0.994	0.000
Z58.7 Exposure to tobacco smoke	0.006	0.994	0.000
Z65.9 Problem related to unspecified psychosocial circumstances	0.006	0.994	0.000
N20.1 Calculus of ureter	0.006	0.994	0.000
Z58.9 Problem related to physical environment, unspecified	0.006	0.994	0.000
Z58.6 Inadequate drinking-water supply	0.006	0.994	0.000
Z58.4 Exposure to radiation	0.006	0.994	0.000
Z58.3 Exposure to soil pollution	0.006	0.994	0.000
Z58.2 Exposure to water pollution	0.006	0.994	0.000
Z58.0 Exposure to noise	0.006	0.994	0.000
Z64.4 Discord with counsellors	0.006	0.994	0.000
Z64.3 Seeking and accepting behavioural and psychological interventions known to be hazardous and harmful	0.006	0.994	0.000
Z64.2 Seeking and accepting physical, nutritional and chemical interventions known to be hazardous and harmful	0.006	0.994	0.000
Z64.1 Problems related to multiparity	0.006	0.994	0.000
C91.0 Acute lymphoblastic leukaemia	0.000	0.994	0.006
Z65.3 Problems related to other legal circumstances	0.006	0.994	0.000
C92 Myeloid leukaemia	0.000	0.994	0.006
C85.1 B-cell lymphoma, unspecified	0.000	0.994	0.006
N20 Calculus of kidney and ureter	0.006	0.994	0.000
Z58.1 Exposure to air pollution	0.006	0.994	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.994	0.006
Z65.5 Exposure to disaster, war and other hostilities	0.006	0.994	0.000
Z65.4 Victim of crime and terrorism	0.006	0.994	0.000
Z65.2 Problems related to release from prison	0.006	0.994	0.000
Z65.1 Imprisonment and other incarceration	0.006	0.994	0.000
Z65.0 Conviction in civil and criminal proceedings without imprisonment	0.006	0.994	0.000
K80.4 Calculus of bile duct with cholecystitis	0.006	0.994	0.000
Z29.2 Other prophylactic chemotherapy	0.006	0.994	0.000
Z55.9 Problems relating to education and literacy, unspecified	0.005	0.994	0.000
Z55.8 Other problems relating to education and literacy	0.005	0.994	0.000
Z55.4 Educational maladjustment and discord with teachers and classmates	0.005	0.994	0.000
Z55.3 Underachievement in school	0.005	0.994	0.000
Z55.2 Failed examinations	0.005	0.994	0.000
Z55.1 Schooling unavailable and unattainable	0.005	0.994	0.000
Z55.0 Illiteracy and low-level literacy	0.005	0.994	0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.005	0.994	0.000
Z62.9 Problem related to upbringing, unspecified	0.005	0.994	0.000
Z62.8 Other specified problems related to upbringing	0.005	0.994	0.000
Z62.6 Inappropriate parental pressure and other abnormal qualities of upbringing	0.005	0.994	0.000
Z62.5 Other problems related to neglect in upbringing	0.005	0.994	0.000
Z62.4 Emotional neglect of child	0.005	0.994	0.000
Z62.3 Hostility towards and scapegoating of child	0.005	0.994	0.000
Z62.2 Institutional upbringing	0.005	0.994	0.000
Z62.1 Parental overprotection	0.005	0.994	0.000
Z62.0 Inadequate parental supervision and control	0.005	0.994	0.000
C94.7 Other specified leukaemias	0.000	0.994	0.005
C94.5 Acute myelofibrosis	0.000	0.994	0.005
C94.3 Mast cell leukaemia	0.000	0.994	0.005
C94.2 Acute megakaryoblastic leukaemia	0.000	0.994	0.005
C94.1 Chronic erythraemia	0.000	0.994	0.005
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.994	0.005
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.995	0.005
C91.7 Other lymphoid leukaemia	0.000	0.995	0.005
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.995	0.005
C91.3 Prolymphocytic leukaemia	0.000	0.995	0.005
C91.2 Subacute lymphocytic leukaemia	0.000	0.995	0.005
C91.4 Hairy-cell leukaemia	0.000	0.995	0.005
C93.9 Monocytic leukaemia, unspecified	0.000	0.995	0.005
C93.7 Other monocytic leukaemia	0.000	0.995	0.005
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.995	0.005
C93.2 Subacute monocytic leukaemia	0.000	0.995	0.005
C93.0 Acute monocytic leukaemia	0.000	0.995	0.005
Z61.6 Problems related to alleged physical abuse of child	0.005	0.995	0.000
Z60.8 Other problems related to social environment	0.005	0.995	0.000
Z61.9 Negative life events in childhood, unspecified	0.005	0.995	0.000
Z61.7 Personal frightening experience in childhood	0.005	0.995	0.000
Z61.3 Events resulting in loss of self-esteem in childhood	0.005	0.995	0.000
Z61.2 Altered pattern of family relationships in childhood	0.005	0.995	0.000
Z61.1 Removal from home in childhood	0.005	0.995	0.000
Z61.0 Loss of love relationship in childhood	0.005	0.995	0.000
C92.0 Acute myeloid leukaemia	0.000	0.995	0.005
K80 Cholelithiasis	0.005	0.995	0.000
Z61.8 Other negative life events in childhood	0.005	0.995	0.000
Z60.9 Problem related to social environment, unspecified	0.005	0.995	0.000
Z65.8 Other specified problems related to psychosocial circumstances	0.005	0.995	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.995	0.005
C88.7 Other malignant immunoproliferative diseases	0.000	0.995	0.005
C88.3 Immunoproliferative small intestinal disease	0.000	0.995	0.005
C88.2 Gamma heavy chain disease	0.000	0.995	0.005
C88.1 Alpha heavy chain disease	0.000	0.995	0.005
C94.4 Acute panmyelosis	0.000	0.995	0.005
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group	0.005	0.995	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.005	0.995	0.000
D27 Benign neoplasm of ovary	0.005	0.995	0.000
C91.5 Adult T-cell leukaemia	0.000	0.995	0.005
N20.9 Urinary calculus, unspecified	0.005	0.995	0.000
Z29.1 Prophylactic immunotherapy	0.005	0.995	0.000
Z59.0 Homelessness	0.005	0.995	0.000
R73.0 Abnormal glucose tolerance test	0.005	0.995	0.000
Z60.5 Target of perceived adverse discrimination and persecution	0.005	0.995	0.000
Z60.4 Social exclusion and rejection	0.005	0.995	0.000
Z60.3 Acculturation difficulty	0.005	0.995	0.000
Z60.1 Atypical parenting situation	0.005	0.995	0.000
Z60.0 Problems of adjustment to life-cycle transitions	0.005	0.995	0.000
Z59.7 Insufficient social insurance and welfare support	0.005	0.995	0.000
Z59.6 Low income	0.005	0.995	0.000
Z59.5 Extreme poverty	0.005	0.995	0.000
Z59.4 Lack of adequate food	0.005	0.995	0.000
Z59.3 Problems related to living in residential institution	0.005	0.995	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.995	0.005
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.995	0.005
E27.8 Other specified disorders of adrenal gland	0.000	0.995	0.005
E27.5 Adrenomedullary hyperfunction	0.000	0.995	0.005
E27.0 Other adrenocortical overactivity	0.000	0.995	0.005
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.995	0.004
Z59.1 Inadequate housing	0.005	0.995	0.000
Z59.2 Discord with neighbours, lodgers and landlord	0.005	0.995	0.000
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.995	0.004
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.995	0.004
C92.3 Myeloid sarcoma	0.000	0.995	0.004
C92.2 Subacute myeloid leukaemia	0.000	0.995	0.004
A63.8 Other specified predominantly sexually transmitted diseases	0.000	0.995	0.004
C82.3 Follicular lymphoma grade IIIa	0.000	0.995	0.004
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.004	0.995	0.000
Z29 Need for other prophylactic measures	0.004	0.995	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.996	0.004
U80 Agent resistant to penicillin and related antibiotics	0.004	0.996	0.000
C92.5 Acute myelomonocytic leukaemia	0.000	0.996	0.004
C90.0 Multiple myeloma	0.000	0.996	0.004
E27.3 Drug-induced adrenocortical insufficiency	0.000	0.996	0.004
C92.4 Acute promyelocytic leukaemia	0.000	0.996	0.004
C93.1 Chronic monocytic leukaemia	0.000	0.996	0.004
O99.8 Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium	0.004	0.996	0.000
C82.2 Large cell, follicular	0.000	0.996	0.004
Z59.8 Other problems relating to housing and economic circumstances	0.004	0.996	0.000
N20.2 Calculus of kidney with calculus of ureter	0.004	0.996	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.996	0.004
K80.3 Calculus of bile duct with cholangitis	0.004	0.996	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.996	0.004
O03.9 Complete or unspecified, without complication	0.004	0.996	0.000
C92.7 Other myeloid leukaemia	0.000	0.996	0.004
S42.2 Fracture of upper end of humerus	0.004	0.996	0.000
K66.8 Other specified disorders of peritoneum	0.000	0.996	0.004
C90.1 Plasma cell leukaemia	0.000	0.996	0.004
K80.8 Other cholelithiasis	0.004	0.996	0.000
H04.2 Epiphora	0.000	0.996	0.004
Z29.8 Other specified prophylactic measures	0.004	0.996	0.000
E24 Cushing's syndrome	0.000	0.996	0.004
C82.6 Cutaneous follicle centre lymphoma	0.000	0.996	0.004
C82.5 Diffuse follicle centre lymphoma	0.000	0.996	0.004
C90.3 Solitary plasmacytoma	0.000	0.996	0.003
E27.9 Disorder of adrenal gland, unspecified	0.000	0.996	0.004
M23.39 Other meniscus derangements (Unspecified ligament or Unspecified meniscus)	0.004	0.996	0.000
E28.3 Primary ovarian failure	0.000	0.996	0.004
Y84.6 Urinary catheterisation	0.004	0.996	0.000
U80.8 Agent resistant to other penicillin-related antibiotic	0.004	0.996	0.000
C82.4 Follicular lymphoma grade IIIb	0.000	0.996	0.003
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.996	0.003
E27.2 Addisonian crisis	0.000	0.996	0.003
E24.9 Cushing's syndrome, unspecified	0.000	0.996	0.003
Z29.9 Prophylactic measure, unspecified	0.003	0.996	0.000
C82.0 Small cleaved cell, follicular	0.000	0.997	0.003
O03.4 Incomplete, without complication	0.003	0.997	0.000
O03 Spontaneous abortion	0.003	0.997	0.000
E20-E35 Disorders of other endocrine glands	0.000	0.997	0.003
E24.0 Pituitary-dependent Cushing's disease	0.000	0.997	0.003
H81.0 Meniere's disease	0.000	0.997	0.003
E28 Ovarian dysfunction	0.000	0.997	0.003
E24.2 Drug-induced Cushing's syndrome	0.000	0.997	0.003
H02.6 Xanthelasma of eyelid	0.003	0.997	0.000
S42.21 Fracture of upper end of humerus (open)	0.003	0.997	0.000
E24.8 Other Cushing's syndrome	0.000	0.997	0.003
C92.1 Chronic myeloid leukaemia	0.000	0.997	0.003
K80.36 Calculus of bile duct with acute and chronic cholangitis without obstruction	0.003	0.997	0.000
K11 Diseases of salivary glands	0.000	0.997	0.003
E34.8 Other specified endocrine disorders	0.000	0.997	0.003
Z48.9 Surgical follow-up care, unspecified	0.003	0.997	0.000
K80.2 Calculus of gallbladder without cholecystitis	0.003	0.997	0.000
E34 Other endocrine disorders	0.000	0.997	0.003
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.003	0.997	0.000
E24.4 Alcohol-induced pseudo-Cushing's syndrome	0.000	0.997	0.003
E24.3 Ectopic ACTH syndrome	0.000	0.997	0.003
E24.1 Nelson's syndrome	0.000	0.997	0.003
O03.1 Incomplete, complicated by delayed or excessive haemorrhage	0.003	0.997	0.000
S02.1 Fracture of base of skull	0.003	0.997	0.000
K11.6 Mucocele of salivary gland	0.000	0.997	0.003
K11.3 Abscess of salivary gland	0.000	0.997	0.003
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.003	0.997	0.000
O03.3 Incomplete, with other and unspecified complications	0.003	0.997	0.000
Z93.1 Gastrostomy status	0.003	0.997	0.000
E25 Adrenogenital disorders	0.000	0.997	0.003
S50.0 Contusion of elbow	0.003	0.997	0.000
Z60.2 Living alone	0.003	0.997	0.000
I70.2 Atherosclerosis of arteries of the extremities	0.003	0.997	0.000
E35 Disorders of endocrine glands in diseases classified elsewhere	0.000	0.997	0.003
E30 Disorders of puberty, not elsewhere classified	0.000	0.997	0.003
U00-U49 Provisional assignment of new diseases of uncertain etiology or emergency use	0.003	0.997	0.000
O03.7 Complete or unspecified, complicated by embolism	0.003	0.997	0.000
O03.5 Complete or unspecified, complicated by genital tract and pelvic infection	0.003	0.997	0.000
O03.2 Incomplete, complicated by embolism	0.003	0.997	0.000
O03.0 Incomplete, complicated by genital tract and pelvic infection	0.003	0.997	0.000
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.997	0.003
E28.9 Ovarian dysfunction, unspecified	0.000	0.997	0.003
E28.8 Other ovarian dysfunction	0.000	0.997	0.003

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations